Skip to main content

Table 1 Description of the continuous surveillance and updating strategy

From: Continuous surveillance of a pregnancy clinical guideline: an early experience

Process Description Participants
1. Recruitment of members for the CG Updating Working Group − Contact the CG Development Group to invite them to participate in the implementation of the strategy.
− Replace non-respondents or those who declined with new members.
− Technical team
2. Mapping of the CG − Identify clinical questions, recommendations, and references in the CG.
− Compile original documentation (searches, references, evidence syntheses, and GRADE evidence profiles).
− Technical team
3. Identification of evidence from the CG Updating Working Group − Distribute a questionnaire via email among the CG Updating Working Group for identifying new evidence. − Clinical team
− Patients and carers team
4. Design of restricted literature search strategy − Design and validate restricted search strategies per clinical question.
− Design search strategy for costs and resources use and for patients’ values and preferences.
− Technical team
5. Running of restricted literature searches − Conduct restricted searches in MEDLINE (through PubMed). − Technical team
6. Review of alerts for drugs and medical devices − Identify alerts for drugs and medical devices issued by the Spanish Agency for Medicines and Health Products. − Technical team
7. Development of references database − Develop references database and identify duplicates among the different information sources and between the original and updated CGs. − Technical team
8. First reference screening − Identify pertinent references (topic-related references with a fitting study design). − Technical team
9. Second reference screening (assessment of new evidence impact) − Develop a questionnaire to identify: (1) relevant references: references that are pertinent for updating a recommendation but that actually do not trigger an update and (2) potential key references: references that could potentially trigger an update of a recommendation. − Clinical team
− Technical team
10. Development of a clinical questions database − Select clinical questions with pertinent, relevant, and key references. − Technical team
11. Classification of clinical questions − Analyse clinical questions database to identify: (1) clinical questions to be reviewed: with potential key references and with different relevant references or important pharmacological alerts, (2) valid clinical questions: without potential key references associated and (3) new clinical questions. − Technical team
12. Review and, if necessary, modification of clinical questions and recommendations − Assessment of the potential key references.
− Update recommendations if necessary.
− Identify key references (references that have triggered changes in one or more recommendations).
− Reach a consensus with the CG Updating Working Group on the suggested updates.
− Clinical team
− Patients and carers team
− Technical team
13. Update of the CG manuscript − Incorporate updates in the previous version of the CG manuscript. − Technical team
  1. CG clinical guideline